Figure 2.
Percentages of patients with mortality and hospitalization outcomes in trials testing nirmatrelvir/ritonavir or molnupiravir against coronavirus disease 2019.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.